Memgen, LLC

Website Links

Description

The Leukemia & Lymphoma Society, headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 5.1 million contacts with patients, caregivers and healthcare professionals.

Memgen is a clinical stage biotechnology company headquartered in Dallas, Texas, that is dedicated to developing therapies that improve overall survival in patients with blood and solid tumor cancers.

Memgen is a biotechnology company with its headquarters in Dallas, TX and an office in Solana Beach, CA. Memgen was founded five years ago to develop targeted active immunotherapies for the treatment of cancers. Its lead product, ISF35, has been well-tolerated while demonstrating potent anti-leukemic activity as a single agent. ISF35 causes none of the immunosuppression associated with standard cancer treatments.

Memgen is a biotechnology company with offices in Dallas, TX and San Diego, CA. Memgen was founded four years ago to develop non-toxic and targeted active immunotherapies for the treatment of cancers. Its lead product, ISF35, has demonstrated potent anti-leukemic activity as a single agent while being well tolerated. ISF35 generates none of the immunosuppression associated with standard cancer treatments.

Products & services

Similar companies nearby